Terms: = Lymphoma AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src
444 results:
1. Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas.
Choi J; Ceribelli M; Phelan JD; Häupl B; Huang DW; Wright GW; Hsiao T; Morris V; Ciccarese F; Wang B; Corcoran S; Scheich S; Yu X; Xu W; Yang Y; Zhao H; Zhou J; Zhang G; Muppidi J; Inghirami GG; Oellerich T; Wilson WH; Thomas CJ; Staudt LM
Cancer Cell; 2024 May; 42(5):833-849.e12. PubMed ID: 38701792
[TBL] [Abstract] [Full Text] [Related]
2. Inhibition of src-3 as a potential therapeutic strategy for aggressive mantle cell lymphoma.
Bijou I; Liu Y; Lu D; Chen J; Sloan S; Alinari L; Lonard DM; O'Malley BW; Wang M; Wang J
PLoS One; 2024; 19(4):e0289902. PubMed ID: 38683834
[TBL] [Abstract] [Full Text] [Related]
3. Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like lymphomas in mice.
Bristol JA; Nelson SE; Ohashi M; Casco A; Hayes M; Ranheim EA; Pawelski AS; Singh DR; Hodson DJ; Johannsen EC; Kenney SC
PLoS Pathog; 2024 Apr; 20(4):e1012132. PubMed ID: 38620028
[TBL] [Abstract] [Full Text] [Related]
4. Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations.
Park SJ; Ju S; Goh SH; Yoon BH; Park JL; Kim JH; Lee S; Lee SJ; Kwon Y; Lee W; Park KC; Lee GK; Park SY; Kim S; Kim SY; Han JY; Lee C
Cancer Res; 2024 May; 84(9):1491-1503. PubMed ID: 38607364
[TBL] [Abstract] [Full Text] [Related]
5. Concurrent inhibition of ALK and src kinases disrupts the ALK lung tumor cell proteome.
Diaz-Jimenez A; Ramos M; Helm B; Chocarro S; Frey DL; Agrawal S; Somogyi K; Klingmüller U; Lu J; Sotillo R
Drug Resist Updat; 2024 May; 74():101081. PubMed ID: 38521003
[TBL] [Abstract] [Full Text] [Related]
6. Design, synthesis, and pharmacological evaluation of novel benzothiazole derivatives targeting LCK in acute lymphoblastic leukemia.
Chen Y; Zhang K; Tan J; Fan Z; Fu Y; Li X; Liu B; Wang G
Bioorg Chem; 2024 Mar; 144():107180. PubMed ID: 38335758
[TBL] [Abstract] [Full Text] [Related]
7. C-peptide in diabetes: A player in a dual hormone disorder?
Dakroub A; Dbouk A; Asfour A; Nasser SA; El-Yazbi AF; Sahebkar A; Eid AA; Iratni R; Eid AH
J Cell Physiol; 2024 May; 239(5):e31212. PubMed ID: 38308646
[TBL] [Abstract] [Full Text] [Related]
8. Ensartinib is effective in the treatment of advanced non-small-cell lung cancer with MET amplification after multi-line ALK-TKIs resistance: a case report.
Yang Y; He X; Xiao W; Bai J; Liu Y
Anticancer Drugs; 2024 Mar; 35(3):292-297. PubMed ID: 38179893
[TBL] [Abstract] [Full Text] [Related]
9. Differential network analysis of ROS1 inhibitors reveals lorlatinib polypharmacology through co-targeting PYK2.
Liao Y; Remsing Rix LL; Li X; Fang B; Izumi V; Welsh EA; Monastyrskyi A; Haura EB; Koomen JM; Doebele RC; Rix U
Cell Chem Biol; 2024 Feb; 31(2):284-297.e10. PubMed ID: 37848034
[TBL] [Abstract] [Full Text] [Related]
10. [Blaps rynchopetera affects proliferation, migration, and invasion of non-small cell lung cancer: a study based on network pharmacology and in vivo and in vitro experiments].
Li XY; Ma K; Yan JN; You FC; Ma L
Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(13):3576-3588. PubMed ID: 37474991
[TBL] [Abstract] [Full Text] [Related]
11. MYD88L265P augments proximal B-cell receptor signaling in large B-cell lymphomas via an interaction with DOCK8.
Mandato E; Yan Q; Ouyang J; Paczkowska J; Qin Y; Hao Y; Bojarczuk K; Hansen J; Chapuy B; Rodig SJ; Khan SJ; Redd RA; Shipp MA
Blood; 2023 Oct; 142(14):1219-1232. PubMed ID: 37467575
[TBL] [Abstract] [Full Text] [Related]
12. Advances in the expression and function of Fyn in different human tumors.
Liu C; Li S; Tang Y
Clin Transl Oncol; 2023 Oct; 25(10):2852-2860. PubMed ID: 37093456
[TBL] [Abstract] [Full Text] [Related]
13. Novel 7-Chloro-4-aminoquinoline-benzimidazole Hybrids as Inhibitors of Cancer Cells Growth: Synthesis, Antiproliferative Activity, in Silico ADME Predictions, and Docking.
Krstulović L; Leventić M; Rastija V; Starčević K; Jirouš M; Janić I; Karnaš M; Lasić K; Bajić M; Glavaš-Obrovac L
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677600
[TBL] [Abstract] [Full Text] [Related]
14. ArtinM Cytotoxicity in B Cells Derived from Non-Hodgkin's lymphoma Depends on Syk and src Family Kinases.
Barboza BR; Thomaz SMO; Junior AC; Espreafico EM; Miyamoto JG; Tashima AK; Camacho MF; Zelanis A; Roque-Barreira MC; da Silva TA
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674590
[TBL] [Abstract] [Full Text] [Related]
15. BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1.
Delage L; Lambert M; Bardel É; Kundlacz C; Chartoire D; Conchon A; Peugnet AL; Gorka L; Auberger P; Jacquel A; Soussain C; Destaing O; Delecluse HJ; Delecluse S; Merabet S; Traverse-Glehen A; Salles G; Bachy E; Billaud M; Ghesquières H; Genestier L; Rouault JP; Sujobert P
Blood; 2023 Mar; 141(10):1209-1220. PubMed ID: 36375119
[TBL] [Abstract] [Full Text] [Related]
16. The noncatalytic regions of the tyrosine kinase Tnk1 are important for activity and substrate specificity.
Ahmed S; Miller WT
J Biol Chem; 2022 Dec; 298(12):102664. PubMed ID: 36334623
[TBL] [Abstract] [Full Text] [Related]
17. Rhodanine Derivatives as Anticancer Agents: QSAR and Molecular Docking Studies.
Molnar M; Lončarić M; Opačak-Bernardi T; Glavaš-Obrovac L; Rastija V
Anticancer Agents Med Chem; 2023; 23(7):839-846. PubMed ID: 36305127
[TBL] [Abstract] [Full Text] [Related]
18. Receptor-kinase EGFR-MAPK adaptor proteins mediate the epithelial response to Candida albicans via the cytolytic peptide toxin, candidalysin.
Ponde NO; Lortal L; Tsavou A; Hepworth OW; Wickramasinghe DN; Ho J; Richardson JP; Moyes DL; Gaffen SL; Naglik JR
J Biol Chem; 2022 Oct; 298(10):102419. PubMed ID: 36037968
[TBL] [Abstract] [Full Text] [Related]
19. src Family Kinase Inhibition Targets YES1 and YAP1 as Primary Drivers of Lung Cancer and as Mediators of Acquired Resistance to ALK and Epidermal Growth Factor Receptor Inhibitors.
Sato H; Kubota D; Qiao H; Jungbluth A; Rekhtman N; Schoenfeld AJ; Yu HA; Riely GJ; Toyooka S; Lovly CM; Paik P; Ladanyi M; Fan PD
JCO Precis Oncol; 2022 Aug; 6():e2200088. PubMed ID: 35952318
[TBL] [Abstract] [Full Text] [Related]
20. Evaluation of Lung Toxicity Related to the Treatment With Alectinib Using a Pharmacovigilance Database.
Sato J; Uchida M; Wakabayashi H; Shimizu T
Anticancer Res; 2022 Jun; 42(6):3109-3116. PubMed ID: 35641286
[TBL] [Abstract] [Full Text] [Related]
[Next]
